CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 233 filers reported holding CORCEPT THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.94 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $549,505 | -65.1% | 20,169 | -71.5% | 0.00% | -100.0% |
| Q2 2023 | $1,575,345 | -46.6% | 70,802 | -65.8% | 0.00% | 0.0% |
| Q1 2023 | $2,948,051 | +9.4% | 207,150 | +56.2% | 0.00% | 0.0% |
| Q4 2022 | $2,693,939 | -15.5% | 132,641 | +6.6% | 0.00% | -50.0% |
| Q3 2022 | $3,189,000 | +13.5% | 124,373 | +5.2% | 0.00% | 0.0% |
| Q2 2022 | $2,810,000 | +12.4% | 118,179 | +6.4% | 0.00% | +100.0% |
| Q1 2022 | $2,501,000 | +50.8% | 111,075 | +32.5% | 0.00% | 0.0% |
| Q4 2021 | $1,659,000 | +10.7% | 83,808 | +10.1% | 0.00% | 0.0% |
| Q3 2021 | $1,498,000 | -0.7% | 76,106 | +11.0% | 0.00% | 0.0% |
| Q2 2021 | $1,508,000 | +14.3% | 68,568 | +23.7% | 0.00% | 0.0% |
| Q1 2021 | $1,319,000 | +16.4% | 55,442 | +28.0% | 0.00% | 0.0% |
| Q4 2020 | $1,133,000 | +69.4% | 43,324 | +12.7% | 0.00% | 0.0% |
| Q3 2020 | $669,000 | +34.9% | 38,440 | +30.3% | 0.00% | – |
| Q2 2020 | $496,000 | +76.5% | 29,508 | +24.8% | 0.00% | – |
| Q1 2020 | $281,000 | +51.9% | 23,644 | +54.8% | 0.00% | – |
| Q4 2019 | $185,000 | -26.3% | 15,270 | -13.9% | 0.00% | – |
| Q3 2019 | $251,000 | +34.9% | 17,727 | +6.1% | 0.00% | – |
| Q2 2019 | $186,000 | -75.5% | 16,712 | -70.6% | 0.00% | -100.0% |
| Q4 2018 | $759,000 | +360.0% | 56,847 | +437.8% | 0.00% | – |
| Q2 2018 | $165,000 | -23.6% | 10,571 | -19.0% | 0.00% | -100.0% |
| Q1 2018 | $216,000 | +4220.0% | 13,054 | +4340.1% | 0.00% | – |
| Q4 2017 | $5,000 | -16.7% | 294 | 0.0% | 0.00% | – |
| Q3 2017 | $6,000 | -84.2% | 294 | -91.1% | 0.00% | – |
| Q2 2017 | $38,000 | +1166.7% | 3,294 | +1020.4% | 0.00% | – |
| Q1 2017 | $3,000 | +50.0% | 294 | 0.0% | 0.00% | – |
| Q4 2016 | $2,000 | -90.0% | 294 | -90.2% | 0.00% | – |
| Q3 2016 | $20,000 | +11.1% | 3,000 | -8.9% | 0.00% | – |
| Q2 2016 | $18,000 | +20.0% | 3,294 | 0.0% | 0.00% | – |
| Q1 2016 | $15,000 | +66.7% | 3,294 | -5.9% | 0.00% | – |
| Q3 2014 | $9,000 | – | 3,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 6,911,376 | $155,644,000 | 6.95% |
| Parallel Advisors, LLC | 1,944,319 | $47,014,000 | 1.86% |
| TANAKA CAPITAL MANAGEMENT INC | 39,289 | $885,000 | 1.79% |
| S&T BANK/PA | 508,546 | $11,452,000 | 1.73% |
| Bridge City Capital, LLC | 83,967 | $1,891,000 | 0.88% |
| Birchview Capital, LP | 50,000 | $1,126,000 | 0.81% |
| Quantedge Capital Pte Ltd | 113,012 | $2,545,000 | 0.75% |
| FAS Wealth Partners, Inc. | 289,625 | $6,522,000 | 0.61% |
| AJ WEALTH STRATEGIES, LLC | 396,029 | $8,919,000 | 0.44% |
| TRUSTCORE FINANCIAL SERVICES, LLC | 208,806 | $4,702,000 | 0.41% |